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The Quiescin-sulfhydryl oxidase (QSOX) family of flavoenzymes catalyzes the direct and facile insertion of disulfide bonds into unfolded
reduced proteins with concomitant reduction of oxygen to hydrogen peroxide. This review discusses the chemical mechanism of these enzymes
and the involvement of thioredoxin and flavin-binding domains in catalysis. The variability of CxxC motifs in the QSOX family is highlighted and
attention is drawn to the steric factors that may promote efficient thiol/disulfide exchange during oxidative protein folding. The varied cellular
location of these multi-domain sulfhydryl oxidases is reviewed and potential intracellular and extracellular roles are summarized. Finally, this
review identifies important unresolved questions concerning this ancient family of sulfhydryl oxidases.
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The name “sulfhydryl oxidase” was first coined by
Kiermeier and coworkers [1,2] to describe an activity in fresh
milk that counteracts the undesirable “burnt” flavors associated
with ultra-high temperature pasteurization [3]. This reaction
involves the generation of disulfide bonds between cysteine
residues of denatured globular proteins [4]:
2RQSH þ O2→RQSQSQR þ H2O2 ð1Þ
This first mammalian sulfhydryl oxidase has been extensively
studied by Swaisgood and coworkers [3–7] and is reported to be
an iron-dependent enzyme capable of oxidizing both glutathi-
one and protein thiol groups. Subsequently, a number of
metalloenzyme sulfhydryl oxidases have been shown to containAbbreviations: ALR, augmenter of liver regeneration; ER, endoplasmic
reticulum; Ero1, endoplasmic reticulum oxidoreductin 1; Erv, a protein essential
for respiration and vegetative growth; GSH, reduced glutathione; GSSG,
oxidized glutathione; PDI, protein disulfide isomerase; QSOX, Quiescin-
sulfhydryl oxidase; Trx, thioredoxin
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doi:10.1016/j.bbamcr.2007.10.002either iron [4,8,9] or copper [10–12]. Although they have been
frequently suggested as participants in mammalian disulfide
bond generation [4,9,12–14], these enzymes remain poorly
understood without published sequences, descriptions of metal
coordination environment, or crystal structures.
In contrast, the last decade has witnessed a growing interest
in sulfhydryl oxidases that utilize flavin as an essential redox-
active cofactor. Table 1 lists representatives of selected
eukaryotic flavoprotein sulfhydryl oxidases in the approximate
order that they were found to be flavin-linked. The first of them
was isolated from mammalian seminal vesicles by Ostrowski
and Kistler in 1979 [15]. Next came reports on glutathione
oxidases from Pencillium species [16] and from Aspergillus
niger [17]. These two enzymes are evolutionarily distinct from
all of the other flavin-linked enzymes in Table 1 [18–20]:
indeed their closest relatives appear to be thioredoxin reductase-
like members of the pyridine nucleotide disulfide oxidoreduc-
tase family [21,22]. The physiological roles of these fungal
enzymes are unclear [20], and they will not be discussed further
in this review.
The avian egg white oxidase listed in Table 1 was found
serendipitously in 1996 [23] and subsequently shown to be
homologous with both the rat seminal vesicle flavoprotein
[18,24] and a series of human growth factors including Quiescin
Q6 [25], bone-derived growth factor [26], cell growth inhibitory
Table 1
Selected flavoprotein sulfhydryl oxidases
Enzyme Source Flavin found Reference
Sulfhydryl oxidase Seminal vesicles 1979 [107]
Glutathione oxidase Penicillium spp. 1982 [16]
Aspergillus niger 1987 [17]
Sulfhydryl oxidase Avian egg white 1996 [23]
Erv1p Yeast 2000 [108]
ALR Rat and human 2001 [109]
Erv2p Yeast 2001 [110,111]
Ero1p Yeast 2000 [31]
2004 [32]
Fig. 1. Pathways illustrating the flow of reducing equivalents during the net
generation of structural disulfide bonds in metazoans. The Ero1 proteins are
believed to accept reducing equivalents from PDI or PDI-like proteins as shown.
In contrast QSOX may oxidize client reduced proteins directly. Additional
pathways for net disulfide generation may exist. The arrows represent the flow
of pairs of reducing equivalents formed during the generation of disulfides.
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Enzymes of this family have come to be called Quiescin-
sulfhydryl oxidases (here abbreviated QSOX). QSOX family
members contain one or more thioredoxin domains and a highly
helical flavin-binding domain (abbreviated here as Erv/ALR).
In addition, this Erv/ALR fold [29,30] is employed in a number
of small stand-alone eukaryotic sulfhydryl oxidases (e.g. yeast
Erv1p, its mammalian counterpart augmenter of liver regener-
ation (ALR), and yeast Erv2p; Table 1). At least one of these
flavoproteins has been found in the genomes of almost every
eukaryote so far examined, together with Ero1, an evolution-
arily distant or unrelated flavoprotein sulfhydryl oxidase
[31,32]. These important flavin-linked oxidases are covered in
separate reviews in this thematic issue, and so will only be
addressed peripherally here.
2. Flavoprotein candidates for oxidative protein folding in
higher eukaryotes
Two distinct flavoprotein oxidases have been proposed to
play roles in the secretory systems of higher eukaryotes. The
Ero1 proteins are believed to be major net generators of
disulfides in the lumen of the ER [31,33–38]. These ER-
resident enzymes are proposed to regenerate PDI after they have
served as the immediate oxidant of client proteins as shown in
Fig. 1. This “PDI first”model of oxidative protein folding raises
interesting issues of mechanism and regulation [39] that cannot
be addressed here. In contrast to the Ero1 proteins, QSOXs
apparently function in reverse. Their direct substrates are
unfolded reduced proteins, and when disulfide bonds begin to
accumulate, reduced PDI isomerizes those that are inserted
incorrectly (see below). While Fig. 1 is a useful summary of
current ideas of oxidative protein folding these models may
require significant revision as they are further examined in vivo
and in vitro. Finally, it should be acknowledged that there may
be pathways for the net generation of disulfides that remain
unrecognized or underappreciated [19].
3. QSOX phylogenetics
It is interesting that the presence of QSOX and Erv2p in
eukaryotes seems to be mutually exclusive [19,20]. While a
detailed phylogenetic analysis of the occurrence of flavin-
dependent oxidases in sequenced genomes is beyond the scopeof this review, a few general observations are pertinent. Erv2p,
but not QSOX, is found in widely divergent fungi including
Saccharomyces cerevisiae, Aspergillus nidulans, Neurospora
crassa, and Encephalitozoon cuniculi [20]. In contrast QSOXs,
but not Erv2p, are found in metazoans, plants and certain
protists [19,20,39]. Gene duplication results in multiple
paralogs of QSOX in metazoans (four in Drosophila melano-
gaster, three in Caenorhabditis elegans, and two in vertebrates
and green plants [19,20]).
The appearance of QSOX predates the emergence of
multicellularity since the fusion of thioredoxin and Erv/ALR
domains occurred before the divergence of yeast/fungi from
other eukaryotes [19,39]. A QSOX sequence is found in the
smallest free-living unicellular eukaryote (a marine algae;
Ostreococcus taurii) [40]. Additionally, a number of unicellular
pathogenic protists (e.g. Plasmodium falciparum, Trypano-
soma brucei, Leishmania major, and Cryptosporidium parvum)
also contain a single QSOX gene. QSOXs from unicellular
organisms might be involved in the elaboration of cell-surface
proteins but nothing is known about their actual roles in vivo or
their enzymological properties in vitro.
4. Models for sulfhydryl oxidase catalysis
Despite the apparent structural diversity of flavoprotein
sulfhydryl oxidases, they show a remarkable convergence of
mechanism [20,29,32,39]. All utilize a flavin ring (contributed
from FAD) in intimate redox communication with an active site
disulfide bond (herein termed the proximal disulfide) as depicted
in Fig. 2 (form 1). The communication between disulfide and
flavin has been thoroughly explored for the pyridine nucleotide
disulfide oxidoreductases [21,22] and these insights continue to
provide useful precedents for the mechanism of the sulfhydryl
oxidases. A catalytic turnover for a prototypical sulfhydryl
oxidase would commence by reduction of the proximal disulfide
(either directly by the substrate (forms 2–5), or indirectly via a
series of disulfide exchanges that bring reducing equivalents
from a more distant locus).
Fig. 2. Steps in the mechanism of a hypothetical flavin-dependent sulfhydryl
oxidase. The flavin and redox-active disulfide common to all sulfhydryl
oxidases are shown within the blue box. The reducing substrate (here a protein
dithiol) and molecular oxygen are shown in salmon. Key steps in the mechanism
are selected for emphasis and some of the deprotonation events are not shown
explicitly.
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expected to have distinct functions. The outer “interchange”
[21,22] cysteine depicted in yellow in Fig. 2 forms mixed
disulfides with incoming substrates (e.g. form 3). The inner
“charge-transfer” sulfur (orange) interacts primarily with the
flavin ring, frequently with the formation of a charge-transfer
interaction [21–23,41,42] between the electron-rich thiolate and
the electron-deficient flavin (depicted by the hatched lines in
forms 3–5). Next, this thiolate attacks the flavin at the C4a
position generating a transitory covalent adduct (form 7)
[21,43–46]. This adduct can then resolve, regenerating the
proximal disulfide and forming the reduced flavin. Form 9 is
thus the end of the reductive half-reaction. Finally, form 1 is
regenerated in the oxidative half-reaction with the net 2-electron
reduction of a molecule of oxygen yielding hydrogen peroxide.
While this reoxidation step has been shown to proceed via the
formation of a C4a-hydroperoxy adduct in certain flavoen-
zymes, it is not clear whether such a covalent species is formed
in the sulfhydryl oxidases, or exactly how this formally spin-
forbidden reaction occurs [47,48]. Fass and coworkers have
identified a potential site by which oxygen might approach the
flavin in Erv2p [49].
Thus, flavins are well suited to serve as redox cofactors for
disulfide generation because they can be readily reduced by
dithiols and facilely reoxidized by oxygen. Enzymes exploiting
this chemistry are true oxidases because they catalyze the
oxidation of their substrates with the direct consumption of
molecular oxygen [39]. However many reduced flavoproteins
can utilize a range of alternate 1- and 2-electron acceptors in
vitro suggesting that disulfide bond generation in eukaryotes
might not always utilize oxygen as an immediate co-substrate.
A particularly interesting example is raised by Herrmann and
colleagues in this series. In that case, yeast Erv1 and its
mammalian counterpart ALR, can generate disulfide bonds
using cytochrome c as an effective terminal oxidant as
suggested in vitro [50] and in vivo [51,52].
Could the catalytic scheme in Fig. 2 be simplified, by
dispensing with the proximal disulfide and using substrate thiol
(ate)s to directly attack the flavin? In this mode the orange
sulfur atom in form 6 would be replaced with the substrate
thiolate in form 2. However such direct interactions would
require that C4a flavin adducts be generated with a huge
number of potential cysteinyl thiols. This may entail significant
steric constraints when the substrates are large. In fact all
sulfhydryl oxidases appear to channel reducing equivalent to
the flavin by way of a common optimally-placed proximal
disulfide bond (as shown in Fig. 2). Further, many of them
employ an additional “distal” or “shuttle” disulfide on a mobile
element of secondary structure that further separates the
substrate from the flavin [29,32,49]. Distal and proximal
disulfides are contained within distinct domains in QSOX
proteins (see below).
One of the reasons for these apparently redundant multiple
disulfide exchange steps may be to move the most sterically de-
manding interactions to flexible distal centers [29,32,49,53,54].
While not widely discussed, disulfide exchange steps, reactions
that are central to both the oxidative and isomerization phases
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constraints [55,56]. As a simple illustration Fig. 3 shows a
mixed disulfide intermediate A–B formed after the attack of a
dithiol-containing protein B on a disulfide-containing pro-
tein A. The subsequent resolution of this disulfide, yielding
reduced A and oxidized B, is favored when the thiolate
nucleophile in B attacks along the S–S axis of the A–B
disulfide [55,56]. Placement of this “resolving” thiolate in an
unfavorable non-linear geometry (e.g. as depicted in the lower
panel of Fig. 3) would then require sufficient protein
flexibility in B (and/or in A) to allow the reacting sulfur
atoms to attain approximate co-linearity. If this reaction
cannot be accomplished efficiently, the mixed disulfide may
simply reverse in favor of the reactants (oxidized A and
reduced B).
5. Domain structure and catalysis in QSOX enzymes
Fig. 4 shows the amino acid sequence of the long form of
human QSOX1 with key features highlighted in color. Two
thioredoxin domains (Trx1 and 2) follow an N-terminal signal
sequence. Trx1 contains a CxxC motif (hereafter CxxC-trx)
with the sequence CGHC that is frequently associated with
eukaryotic protein disulfide isomerases (PDI; see below [57–
60]). Partial proteolysis studies of avian QSOX showed that this
domain is crucial for the rapid oxidation of unfolded protein
substrates [61]. These experiments also suggested that it is this
CxxC-trx motif that is first reduced by protein substrates and
subsequently passes reducing equivalents to the Erv/ALR
domain [61]. Homology models of both these catalytic
domains, together with an indication of the flow of reducing
equivalents between them, are shown in Fig. 5.Fig. 3. A representation of favored and disfavored orientation for disulfide
exchange. Top and bottom panels depict reactions involving a mixed disulfide
between proteinsA and B. Surface accessible and buried sulfur atoms are shown
as yellow and orange spheres, respectively.The second thioredoxin module in metazoan QSOXs is not
identified by standard sequence analysis programs: it contains
the same alternation of secondary structural elements found for
Trx1 but omits the first short beta-strand (Fig. 4). This Trx2
domain lacks a CxxC motif and is fused to a third “spacer”
domain of about 100 amino acids. Database searches with this
spacer sequence do not reveal compelling non-QSOX matches,
but secondary structure prediction programs suggest that it is
substantially helical (Fig. 4). The final domain in QSOXs is the
Erv/ALR module whose novel flavin-binding fold, first
established by Fass and coworkers for yeast Erv2p [29], serves
as the model for the corresponding domain in QSOX (Fig. 5).
The isoalloxazine ring is inserted into the mouth of a four-helix
bundle with the proximal disulfide situated at a turn between
helices 2 and 3. The interchange sulfur is solvent exposed
whereas the charge-transfer sulfur is buried and almost touching
the C4a position of the flavin. Overall, the placement of both
interchange and charge-transfer sulfur atoms seems perfectly
adapted for the reactions depicted in Fig. 2: for the
accommodation of a mixed disulfide intermediate with external
protein reductants, and for the subsequent formation and
resolution of the C4a flavin adduct.
Domain motions are likely to be an important feature of
catalysis in QSOX: the CxxC-trx motif must alternately form
covalent intermediates between potentially large protein sub-
strates and the Erv/ALR domain (Fig. 5). The observation that a
relatively slow (3 /s at 4 °C) protein isomerization event limits
oxidation of thiol substrates by the avian enzyme [41] is
certainly consistent with these expectations. Such motions
might be accommodated via the disordered regions that are
predicted to flank both the N- and C-termini of Trx1 and Erv1/
ALR domains of QSOX (Fig. 4).
The catalytic model in Fig. 5 envisages critical roles for two
CxxC motifs, but it omits a third CxxC feature which is
conserved in every metazoan, plant and protist QSOX sequence
examined to date (see below). This feature is located at a
comparable position to a CxC motif believed to act as the
mobile shuttle disulfide in Erv2p [29,49]. This analogy, together
with the finding that avian QSOX can accept a total of 8-
electrons under forcing conditions (three disulfides and one
flavin), prompted our earlier proposal that this C-terminal CxxC
motif plays a comparable shuttle role in QSOX [61].
Surprisingly, recent site-directed mutagenesis experiments
with human QSOX1, demonstrate that this motif is not essential
for the oxidation of the reduced forms of glutathione,
dithiothreitol, or RNase (Heckler, E., Alon, A., Fass, D., and
Thorpe, C., unpublished observations). The roles of this
conserved CxxC motif are currently unknown.
While metazoan QSOXs contain two thioredoxin domains
[20,61], plants and protists lack a complete Trx2 domain but
retain the spacer and Erv/ALR domains [20]. All QSOX
sequences so far examined share a rather divergent and partly
unstructured C-terminal sequence of amino acids which often
ends with a single transmembrane span [20]. Differential
splicing leads to two forms of human QSOX. The longer (747
residues) form retains the membrane span, and is likely to be
anchored at a membrane surface, or subsequently freed from its
Fig. 5. The flow of reducing equivalents in a monomeric QSOX. Homology models of the Trx1 and Erv/ALR domains were constructed using the crystal structures of
yeast PDI1 a domain [59] and yeast Erv2p [29] respectively. Surface accessible and buried sulfur atoms are shown as yellow and orange spheres, respectively.
Fig. 4. Amino acid sequence, secondary structure and domain organization of the long form of human QSOX1 (NP_002817). The three CxxC motifs are shown in red
(CxxC-trx, CxxC-erv, and CxxC-trm). The predicted signal sequence (navy blue), and Trx1 (blue), Trx2 (light blue), spacer (grey), and Erv/ALR (dark green) domains,
and the transmembrane span (light green) are highlighted. Helices and strands are shown by bright green cylinders and yellow arrows respectively. Predicted
disordered regions are underlined in dashed red [112–114].
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Fig. 6. Sequence variability within the three CxxC motifs of QSOXs of animals,
plants and protists. A total of 72 unique QSOX gene products (omitting
differentially spliced products) are color coded by animals (red), plants and
algae (green), and protists (yellow). Currently animals are overrepresented in the
available sequences (comprising about 50% of the total).
572 E.J. Heckler et al. / Biochimica et Biophysica Acta 1783 (2008) 567–577attachment by proteolysis. The shorter form contains 604
residues and lacks the transmembrane helix. A priori one would
not expect long and short forms of QSOX to differ in their
intrinsic catalytic specificity because both retain the same core
catalytic domains. Conventional C-terminal ER retention
sequences are absent in QSOX.
6. The variability of CxxC sequences in QSOX
There has been considerable interest in the influence of the
intervening residues on the redox potential and reactivity of
CxxC motifs in DsbA, PDI and thioredoxin, [62–66]. As
mentioned above, the CxxC-trx motif occurs at the junction
between a loop and a helix. Interestingly, the CxxC-erv motif is
also placed at a loop–helix junction, but occurs within the context
of a 4-helix bundle (Fig. 5). The third CxxC (CxxC-trm) is
located immediately C-terminal to the Erv/ALR domain (Fig. 5,
top) in what may be a flexible region of the protein. Although
the role of CxxC-trm is now uncertain, we have included
this conserved feature in the following sequence analysis.
Fig. 6 is a compilation based on the translated sequences
from 72 unique QSOX genes. By far the most conserved are
those for CxxC-trx: those of CxxC-erv and CxxC-trm are much
more variable. Thus the most prevalent CxxC-trx sequence is
CGHC: a motif widely found in eukaryotic PDIs [57,58,60].
Since the CxxC-trx and CxxC-erv motifs are links in a chain of
redox centers between reduced protein client and molecular
oxygen (Fig. 5), one might expect a significant degree of mutual
sequence conservation in these motifs. Contrary to this
prediction, CxxC-erv is highly variable, with 29 different
combinations of the intervening dipeptide among the sequences
examined (Fig. 6, middle panel). The intervening xx dipeptide
is generally polar: 80% of these sequences contain at least one
charged amino acid and about 50% of the animal sequences
have two oppositely charged residues (KE, RD, RE or EH). All
plant CxxC-erv sequences examined comprise negatively
charged residues (DD, EE, DE, ED). It will be interesting to
learn what factors direct the relative conservation of the CxxC-
trx motif compared to the diversity of CxxC-erv sequences. It
seems paradoxical that the former likely interacts with a
multiplicity of client peptide and proteins [20,67,68], whereas
the more variable CxxC-erv motif may have just two partners:
the reduced thioredoxin domain and the oxidized flavin
prosthetic group (Fig. 5).
Finally, CxxC-trm sequences are also highly variable with 30
different intervening dipeptides. There appears no clear
correlation between sequence and organism type. Two modest
generalities emerge from the CxxC-trm sequence comparisons
in Fig. 6: greater than half of X1 residues are proline and about
2/3 of X1 and X2 residues are neutral.
2 GSH þ PDIox ↔GSQSG þ PDIred ð2Þ
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QSOX enzymes are the only flavoprotein sulfhydryl oxidases
described to date that are capable of a direct and facile formation
of disulfide bonds in unfolded reduced proteins [20,39,67]. They
remain the only flavin-linked sulfhydryl oxidases for which
catalytic efficiencies (kcat/KM values) have been measured for
their presumed cognate substrates [23,41,67].
Steady-state kinetic parameters for the avian, bovine (Jaje, J.,
and Thorpe, C., unpublished data) and human QSOX1
(Heckler, E., Alon, A., Fass, D, and Thorpe, C., unpublished
observations) enzymes are comparable: averaging about 1000
disulfide bonds inserted into unfolded reduced proteins per
minute with KM values of about 150 μM per thiol residue.
Hence the insights gained from mechanistic studies of the avian
enzyme are likely to be generally applicable to other vertebrate
QSOXs.
Typically, “unfolded substrates” for QSOX are obtained by
exhaustive reduction of secreted proteins (such as RNase or
lysozyme) under denaturing conditions followed by the removal
of excess reductant [41,67]. These reduced proteins, freed from
the restraints of their native disulfide pairings, assume a
somewhat expanded molten-globule-like state that allows rapid
access of their cysteine residues to small oxidants like 5,5′
dithiobis(2-nitrobenzoate) and, evidently, to the catalytic
apparatus of the QSOX enzymes (see above). However, avian
QSOX cannot reach buried thiols in folded protein structures:
these cysteines remain unreactive to QSOX unless they are
previously exposed by denaturation [67]. It is not yet clear
whether QSOX can efficiently oxidize vicinal cysteine residues
when they are located at the surface of a well-ordered native
folded structure, or whether it can effectively catalyze
intersubunit or interprotein disulfide bonds. In these cases the
steric constraints on disulfide exchange reactions that were
mentioned earlier may assume great significance.
The avian, bovine and human QSOX1 enzymes are all rather
weakly reactive towards reduced GSH [23,41,67]. Here kcat/KM
values are some 100-fold lower than those shown by a typical
unfolded substrate. By this measure, unfolded proteins are
clearly preferred substrates over glutathione. However the
effective concentrations of these potentially competing sub-
strates are unknown in the several intra- and extracellular
locations in which QSOX has been found (see below).
8. QSOX cellular locations and potential intracellular
substrates
Immunohistochemical localization shows that QSOXs have
been found in a variety of cellular locations including the ER
[19,69], Golgi [19,68–70], secretory granules [69,70], and at
the nuclear and plasma membrane surfaces [71]. A V5 tagged
construct of the long form, HsQSOX1a, is found to concentrate
in the Golgi of Chinese hamster ovary cells [68]. Short forms of
QSOX, either the products of differential splicing or possibly of
proteolysis, transit the secretory apparatus as they exit the cell
(there are no obvious retention sequences in this form). Further,
glycosylation of the QSOX short form, HsQSOX1b, is notrequired for enzymatic activity (Heckler, E., Alon, A., Fass, D.,
and Thorpe, C., unpublished observations). An important
unresolved issue [68] is whether these shorter forms contribute
to disulfide generation in the ER. Can QSOX serve multiple
functions: first contributing to net disulfide bond generation
within the ER, and then playing additional roles after secretion?
Before this suggestion can be dismissed, one needs to ensure
that the localization methods for QSOX are of sufficient
sensitivity to detect what may be very low steady-state
concentrations of QSOX in the ER. High concentrations of
QSOX might not be needed here: nanomolar levels of QSOX
rapidly insert disulfides into micromolar levels of reduced
proteins [67].
It should be stressed that there is currently no direct evidence
that the short forms of QSOX are important players in the net
generation of disulfide bonds in the ER. Nevertheless, if active
QSOX is present, what potential thiol substrates would it
encounter? First, the general permeability of the ER membrane
to GSH [72,73] suggests that this tripeptide will be an abundant
thiol species within the ER lumen. However, the relatively high
KM for GSH (20 mM for the avian enzyme), and its 100-fold
lower kcat/KM value compared to the cysteine residues of
unfolded reduced proteins, suggest that GSH is not the preferred
substrate of QSOX within the ER [39,67]. A second category of
potential substrates is the PDIs (and PDI-like proteins). In
aggregate the PDIs probably contribute mM levels of redox-
active thiols to the mammalian ER; presumably maintained
largely in their reduced states by rapid equilibration with the
prevailing GSH/GSSG levels [74,75]:However, reduced PDI (up to 1 mM CxxC thiols) is not a
significant substrate of QSOX (Rancy, P., Winther, J.R., and
Thorpe, C., unpublished observations). This notable unreactiv-
ity may partly reflect steric arguments (see above) and the fact
that reduced mammalian PDI is a relatively weak thermody-
namic reductant compared to an average pair of juxtaposed
thiols in an unfolded protein [76].
QSOX is likely to be highly active towards a third class of
potential substrates: the nascent protein chains extruded into the
ER [67]. In vitro experiments demonstrate a facile cooperation
between QSOX and PDI in introducing and isomerizing
disulfides in a range of protein clients. In the initial work
[67], catalytic levels of PDI were used with QSOX to effect the
rapid oxidative refolding of reduced pancreatic RNase. Here
1 mM GSH was included to maintain PDI in its reduced state.
However glutathione is unnecessary when concentrations of
reduced PDI are used that approach the levels believed to be
present in the mammalian ER [36,58,77]. With this simple
system (1–100 nM QSOX, 30–200 μM reduced PDI and low
micromolar concentrations of reduced client protein), QSOX is
able to selectively oxidize a range of unfolded proteins while
reduced PDI efficiently isomerizes incorrect pairings as they
arise (Rancy, P., Winther, J.R., and Thorpe, C., unpublished
observations). These in vitro studies suggest that if QSOX was
active in the ER it could selectively introduce disulfide bonds in
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glutathione redox poise [39].
9. QSOX tissue distribution
The most extensive work on the physiological locations and
roles of the QSOXs has focused on the rat. Immunohisto-
chemistry of rat QSOX showed that expression is seen in the
immune, reproductive, respiratory, and digestive systems along
with the retina and skin [78]. Specifically, expression is highest
in various secretory endocrine glands (e.g. hypothalamus,
pituitary, pineal, and adrenal) and in the pancreatic islets
of Langerhans; secretory and epithelial cells of the trachea,
stomach, small intestine, salivary glands, esophagus and lung;
and in the reproductive organs (testis, seminal vesicles, vagina,
and ovary) [78]. The expression pattern of rat QSOX is
consistent with data from guinea pig and human QSOX
[19,20,39,79].
Extensive studies on the distribution and ontogenesis of
QSOX in rodent brain have shown specific expression in many
locales, especially those dealing with motor and sensory aspects
and with hormone secretion [69,70,78,80–83]. These investiga-
tions suggest roles for QSOX in the secretion, maintenance, and
maturation of a wide range of disulfide-containing peptides and
proteins as well as in neuronal maturation and synaptic
strengthening [70,82,83]. QSOX may also contribute to redox
cell signaling in the brain via the generation of hydrogen
peroxide [70], which might play a role in a variety of signaling
cascades both within [84] and outside the brain [85].
Musard and coworkers report that guinea pig QSOX is
involved in negative cell cycle control and is down-regulated by
estrogen in the endometrium [79]. A similar effect of estrogen
on QSOX expression is seen in breast cancer cells [86]. Tury et
al. observed changes in QSOX levels during the rat estrus cycle,
but determined that estrogen up-regulated QSOX expression in
the pituitary of ovary-less rats [69]. These divergent results may
be due to tissue or species differences, or reflect the complexity
of estrogen action [69]. High levels of expression of QSOX in
the rat hypothalamic–pituitary neuroendocrine axis were
described by Mairet-Coello et al. and suggest a role for
QSOX in the redox regulation of hormone action [70]. QSOX
and disulfide-containing hormones, especially luteinizing and
follicle stimulating hormones, co-localize to the same neuronal
clusters in a rat brain [69,70]. Interestingly, QSOX is also up-
regulated in pituitary tumors from mice overexpressing
luteinizing hormone [87].
10. Qsox2
Database profiles for the abundance of QSOX1 andQSOX2 in
a range of tissues show that the former appears to be usually
several-fold more abundant than the latter [20]. HsQSOX2 shows
37% identify with its more abundant paralog and shares all of the
key features of the sequence depicted in Fig. 4. QSOX2 has yet to
be characterized enzymatically and is therefore not given
extensive coverage here. There are, however, two interesting
aspects of mammalian QSOX2 that deserve comment.First, Schwab and coworkers identified QSOX2 in a screen
for genes that maintain sensitivity to proapoptotic stimuli in
neuroblastoma cells [71]. They suggested that QSOX2 is a
positive mediator of programmed cell death [71]. Second,
examination of the expression of QSOX2 during mouse dev-
elopment shows that by far the highest abundance of transcripts
occurs in the oocyte [88]. This level drops precipitously (about
100-fold) seemingly following fertilization. Conceivably a
sulfhydryl oxidase may be involved in the deployment of
protein disulfide bonds that accompanies the hardening of the
oocyte extracellular matrix during the slow block to polyspermy
[89,90].
11. QSOX1 and growth regulation
Human QSOX1 was first identified as a gene product
(Quiescin Q6) that was strongly up-regulated when fibroblasts
approach confluence [25,91]. Several other growth-regulating
proteins with names suggestive of significant cellular roles
appear to be QSOX1 [19,20]: bone-derived growth factor [26],
cell growth inhibiting factor [27], placental-derived prostrate
growth factor [92], and erythroid cell stimulating factor [93].
A molecular explanation of the effects of QSOX in any of
these processes has yet to appear. Some of these effects
may involve the proposed role of QSOX in the fabrication/
remodelling of the extracellular matrix [19]. Attention has
already been drawn to the correlated expression between
QSOX1 and a number of proteins of the extracellular matrix
(including collagen IV α1 and lysyl oxidase) in human cancer
cell lines [20,39].
12. QSOX secreted from cells
QSOX1 was first found in rat seminal vesicles [15,24] and
then as a secreted product of the avian oviduct [23]. A
particularly interesting observation is the presence of apprecia-
ble levels of QSOX in mammalian sera [94,95]. Recently
QSOX1 has been isolated from bovine milk (Jaje, J., and
Thorpe, C., unpublished data). QSOX1 is also released from a
range of cell types in tissue culture including human embryo
lung fibroblasts particularly as they approach confluence
[25,91], from Chinese hamster ovary cells [24], from prostrate
cancer cells [92,96], breast cancer cell lines [97], and
osteosarcoma cells [92].
A variety of hypotheses have been proposed to address why
QSOX enzymes are released from cells. These include: to
generate hydrogen peroxide as part of an antimicrobial system
[15] perhaps driven by the export of reduced glutathione [20];
for hydrogen peroxide signaling in the brain [70]; in the
fabrication of disulfide bridged structures that are too bulky to
be assembled intracellularly [20], to continue protein folding
outside the cell [78]; to counteract the effects of extracellular
reductants [68], and in the preservation of sperm membrane
integrity [15,24]. Several of these proposed functions would be
expected to modulate extracellular thiol/disulfide redox poise
and therefore may affect a range of important redox-linked
processes. These include: platelet activation [98,99], cellular
575E.J. Heckler et al. / Biochimica et Biophysica Acta 1783 (2008) 567–577adhesion [100], viral fusion [99,101], cellular proliferation
[102,103], tumor immune evasion [104] and metastatic
potential [105,106]. In these contexts the reported presence of
long-form QSOX enzymes at the cell surface is intriguing.
13. Some outstanding questions
Despite a number of important recent contributions to
the QSOX literature, many fundamental questions remain to
be addressed definitively. For example, do the physiological
functions of QSOX reflect their impressive abilities to insert
disulfide bonds in unfolded proteins? Can QSOX isoforms
generate disulfides in the ER, or would their activities be
deleterious at that location [68]? What roles do secreted
QSOX proteins assume in the extracellular matrix and why
have they been reported to be mammalian growth factors? Do
mammalian QSOX1 and QSOX2 have fundamentally different
cellular roles? Finally, what are the outcomes of QSOX
knockouts in the mouse? Hopefully the next few years will
reveal a clearer understanding of the mechanisms and phy-
siological roles of these enigmatic flavin-dependent sulfhydryl
oxidases.
Acknowledgements
The authors' laboratory is supported by NIH grant
GM26643. P.C.R. was supported, in part, by NIH Training
Grant T32GM08550.
References
[1] F. Kiermeier, K. Ranfft, About some characteristics of sulfhydryl oxidase
in milk, Z. Lebensm.-Unters. -Forsch. 143 (1970) 11–15.
[2] F. Kiermeier, E. Petz, A sulfhydryl group-oxidizing enzyme in milk: II
influence of heating on milk and whey, Z. Lebensm.-Unters. -Forsch. 134
(1967) 97–102.
[3] H. Swaisgood, V. Janolino, Mammalian sulfhydryl oxidase, Food Sci.
Technol. 122 (2003) 539–546.
[4] V.G. Janolino, H.E. Swaisgood, Isolation and characterization of
sulfhydryl oxidase from bovine milk, J. Biol. Chem. 250 (1975)
2532–2538.
[5] V.G. Janolino, H.E. Swaisgood, Sulfhydryl oxidase-catalyzed formation
of disulfide bonds in reduced ribonuclease, Arch. Biochem. Biophys. 258
(1987) 265–271.
[6] V.G. Janolino, H.E. Swaisgood, A comparison of sulfhydryl oxidase from
bovine milk and Aspergillus niger, Milchwissenschaft 47 (1992)
143–146.
[7] H.E. Swaisgood, H.R. Horton, Sulfhydryl oxidase: oxidation of
sulphydryl groups and the formation of three-dimensional structure in
proteins, Ciba Found. Symp. 72 (1980) 205–222.
[8] D.A. Clare, H.R. Horton, T.J. Stabel, H.E. Swaisgood, J.G. Lecce, Tissue
distribution of mammalian sulfhydryl oxidase, Arch. Biochem. Biophys.
230 (1984) 138–145.
[9] D.A. Clare, I.B. Pinnix, J.G. Lecce, H.R. Horton, Purification and
properties of sulfhydryl oxidase from bovine pancreas, Arch. Biochem.
Biophys. 265 (1988) 351–361.
[10] H. Yamada, Localization in skin, activation and reaction mechanisms of
skin sulfhydryl oxidase, Nippon Hifuka Gakkai Zasshi 99 (1989)
861–869.
[11] L.H. Lash, D.P. Jones, Characterization of the membrane-associated thiol
oxidase activity of rat small-intestinal epithelium, Arch. Biochem.
Biophys. 225 (1983) 344–352.[12] R.A. Roth, M.E. Koshland, Identification of a lymphocyte enzyme that
catalyzes pentamer immunoglobulin M assembly, J. Biol. Chem. 256
(1981) 4633–4639.
[13] L.H. Lash, D.P. Jones, Purification and properties of the membranal thiol
oxidase from porcine kidney, Arch. Biochem. Biophys. 247 (1986)
120–130.
[14] V.G. Janolino, M.X. Sliwkowski, H.E. Swaisgood, H.R. Horton,
Catalytic effect of sulfhydryl oxidase on the formation of three-
dimensional structure in chymotrypsinogen A, Arch. Biochem. Biophys.
191 (1978) 269–277.
[15] M.C. Ostrowski, W.S. Kistler, Properties of a flavoprotein sulfhydryl
oxidase from rat seminal vesicle secretion, Biochemistry 19 (1980)
2639–2645.
[16] H. Kusakabe, A. Kuninaka, H. Yoshino, Purification and properties of a
new enzyme, glutathione oxidase from Penicillium sp. K-6-5, Agric.
Biol. Chem. 46 (1982) 2057–2067.
[17] R.S. de la Motte, F.W. Wagner, Aspergillus niger sulfhydryl oxidase,
Biochemistry 26 (1987) 7363–7371.
[18] K.L. Hoober, N.M. Glynn, J. Burnside, D.L. Coppock, C. Thorpe,
Homology between egg white sulfhydryl oxidase and quiescin Q6 defines
a new class of flavin-linked sulfhydryl oxidases, J. Biol. Chem. 274
(1999) 31759–31762.
[19] C. Thorpe, K. Hoober, S. Raje, N. Glynn, J. Burnside, G. Turi,
D. Coppock, Sulfhydryl oxidases: emerging catalysts of protein disulfide
bond formation in eukaryotes, Arch. Biochem. Biophys. 405 (2002)
1–12.
[20] D.L. Coppock, C. Thorpe, Multidomain flavin-dependent sulfhydryl
oxidases, Antioxid. Redox Signal. 8 (2006) 300–311.
[21] C.H. Williams Jr., Lipoamide dehydrogenase, glutathione reductase,
thioredoxin reductase, and mercuric ion reductase—a family of
flavoenzyme transhydrogenases, in: F. Müller (Ed.), Chemistry and
Biochemistry of Flavoenzymes, Chemistry and Biochemistry of
Flavoenzymes, CRC Press, 1992, pp. 121–211.
[22] A. Argyrou, J.S. Blanchard, Flavoprotein disulfide reductases: advances
in chemistry and function, Prog. Nucleic Acid Res. Mol. Biol. 78 (2004)
89–142.
[23] K.L. Hoober, B. Joneja, H.B. White III, C. Thorpe, A sulfhydryl oxidase
from chicken egg white, J. Biol. Chem. 271 (1996) 30510–30516.
[24] B. Benayoun, A. Esnard-Fève, S. Castella, Y. Courty, F. Esnard, Rat semi-
nal vesicle FAD-dependent sulfhydryl oxidase: biochemical characteriza-
tion and molecular cloning of a member of the new sulfhydryl oxidase/
quiescin Q6 gene family, J. Biol. Chem. 276 (2001) 13830–13837.
[25] D.L. Coppock, C. Kopman, S. Scandalis, S. Gillerman, Preferential gene
expression in quiescent human lung fibroblasts, Cell Growth Differ. 4
(1993) 483–493.
[26] C. Gao, H.E. Zhau, B.-Q. Chen and L.W.K. Chung. GenBank accession:
AAA89173 1996.
[27] R. Sasada, K. Igarashi, M. Takeyama, Takeda Chem, Ind. Ltd., Japan,
1998.
[28] C.L. Farrell, F.H. Martin and R. Yabkowitz. pp. 1–28, Amgen Inc., USA
2000.
[29] E. Gross, C.S. Sevier, A. Vala, C.A. Kaiser, D. Fass, A new FAD-binding
fold and intersubunit disulfide shuttle in the thiol oxidase Erv2p, Nat.
Struct. Biol. 9 (2002) 61–67.
[30] C.K. Wu, T.A. Dailey, H.A. Dailey, B.C. Wang, J.P. Rose, The crystal
structure of augmenter of liver regeneration: a mammalian FAD-
dependent sulfhydryl oxidase, Protein Sci. 12 (2003) 1109–1118.
[31] B.P. Tu, S.C. Ho-Schleyer, K.J. Travers, J.S. Weissman, Biochemical
basis of oxidative protein folding in the endoplasmic reticulum, Science
290 (2000) 1571–1574.
[32] E. Gross, D.B. Kastner, C.A. Kaiser, D. Fass, Structure of Ero1p, source
of disulfide bonds for oxidative protein folding in the cell, Cell 117
(2004) 601–610.
[33] A.R. Frand, C.A. Kaiser, Ero1p oxidizes protein disulfide isomerase in a
pathway for disulfide bond formation in the endoplasmic reticulum, Mol.
Cell 4 (1999) 469–477.
[34] A. Cabibbo, M. Pagani, M. Fabbri, M. Rocchi, M.R. Farmery,
N.J. Bulleid, R. Sitia, ERO1-L, a human protein that favors disulfide
576 E.J. Heckler et al. / Biochimica et Biophysica Acta 1783 (2008) 567–577bond formation in the endoplasmic reticulum, J. Biol. Chem. 275 (2000)
4827–4833.
[35] C.S. Sevier, C.A. Kaiser, Conservation and diversity of the cellular
disulfide bond formation pathways, Antioxid. Redox Signal. 8 (2006)
797–811.
[36] A. Mezghrani, A. Fassio, A. Benham, T. Simmen, I. Braakman, R. Sitia,
Manipulation of oxidative protein folding and PDI redox state in
mammalian cells, EMBO J. 20 (2001) 6288–6296.
[37] S.N. Molteni, A. Fassio, M.R. Ciriolo, G. Filomeni, E. Pasqualetto,
C. Fagioli, R. Sitia, Glutathione limits Ero1-dependent oxidation in the
endoplasmic reticulum, J. Biol. Chem. 279 (2004) 32667–32673.
[38] E. van Anken, I. Braakman, Versatility of the endoplasmic reticulum
protein folding factory, Crit. Rev. Biochem. Mol. Biol. 40 (2005)
191–228.
[39] C. Thorpe, D.L. Coppock, Generating disulfides in multicellular
organisms: emerging roles for a new flavoprotein family, J. Biol.
Chem. 282 (2007) 13929–13933.
[40] E. Derelle, C. Ferraz, S. Rombauts, P. Rouze, A.Z. Worden, S. Robbens,
F. Partensky, S. Degroeve, S. Echeynie, R. Cooke, Y. Saeys, J. Wuyts,
K. Jabbari, C. Bowler, O. Panaud, B. Piegu, S.G. Ball, J.P. Ral, F.Y.
Bouget, G. Piganeau, B. De Baets, A. Picard, M. Delseny, J. Demaille, Y.
Van de Peer, H. Moreau, Genome analysis of the smallest free-living
eukaryote Ostreococcus taurii unveils many unique features, Proc. Natl.
Acad. Sci. U. S. A. 103 (2006) 11647–11652.
[41] K.L. Hoober, C. Thorpe, Egg white sulfhydryl oxidase: kinetic
mechanism of the catalysis of disulfide bond formation, Biochemistry
38 (1999) 3211–3217.
[42] G. Hofhaus, J.E. Lee, I. Tews, B. Rosenberg, T. Lisowsky, The
N-terminal cysteine pair of yeast sulfhydryl oxidase Erv1p is essential
for in vivo activity and interacts with the primary redox centre, Eur. J.
Biochem. 270 (2003) 1528–1535.
[43] M.E. O'Donnell, F.A. Johnson, C.H. Williams Jr., Proton nuclear
magnetic resonance investigation of the mechanism of flavin C-4a adduct
formation induced by oxidized nicotinamide adenine dinucleotide
binding to monoalkylated pig heart lipoamide dehydrogenase, Biochem-
istry 22 (1983) 3792–3796.
[44] M.E. O'Donnell, C.H. Williams Jr., Reconstitution of Escherichia coli
thioredoxin reductase with 1-deazaFAD. Evidence for 1-deazaFAD C-4a
adduct formation linked to the ionization of an active site base, J. Biol.
Chem. 259 (1984) 2243–2251.
[45] C. Thorpe, C.H. Williams, Spectral evidence for a flavin adduct in a
monoalkylated derivative of pig heart lipoamide dehydrogenase, J. Biol.
Chem. 251 (1976) 7726–7728.
[46] S.M. Miller, V. Massey, D. Ballou, C.H. Williams Jr., M.D. Distefano,
M.J. Moore, C.T. Walsh, Use of a site-directed triple mutant to trap
intermediates: demonstration that the flavin C(4a)-thiol adduct and
reduced flavin are kinetically competent intermediates in mercuric ion
reductase, Biochemistry 29 (1990) 2831–2841.
[47] V. Massey, Activation of molecular oxygen by flavins and flavoproteins,
J. Biol. Chem. 269 (1994) 22459–22462.
[48] A. Mattevi, To be or not to be an oxidase: challenging the oxygen
reactivity of flavoenzymes, Trends Biochem. Sci. 31 (2006) 276–283.
[49] E. Vitu, M. Bentzur, T. Lisowsky, C.A. Kaiser, D. Fass, Gain of function
in an ERV/ALR sulfhydryl oxidase by molecular engineering of the
shuttle disulfide, J. Mol. Biol. 362 (2006) 89–101.
[50] S.R. Farrell, C. Thorpe, Augmenter of liver regeneration: a flavin
dependent sulfhydryl oxidase with cytochrome C reductase activity,
Biochemistry 44 (2005) 1532–1541.
[51] S. Allen, V. Balabanidou, D.P. Sideris, T. Lisowsky, K. Tokatlidis, Erv1
mediates the Mia40-dependent protein import pathway and provides a
functional link to the respiratory chain by shuttling electrons to
cytochrome c J. Mol. Biol. (2005).
[52] J.M. Herrmann, R. Kohl, Catch me if you can! Oxidative protein trapping
in the intermembrane space of mitochondria, J. Cell Biol. 176 (2007)
559–563.
[53] C.S. Sevier, C.A. Kaiser, Disulfide transfer between two conserved
cysteine pairs imparts selectivity to protein oxidation by Ero1, Mol. Biol.
Cell 17 (2006) 2256–2266.[54] A. Vala, C.S. Sevier, C.A. Kaiser, Structural determinants of substrate
access to the disulfide oxidase Erv2p, J. Mol. Biol. 354 (2005) 952–966.
[55] P.A. Fernandes, M.J. Ramos, Theoretical insights into the mechanism for
thiol/disulfide exchange, Chemistry 10 (2004) 257–266.
[56] R.E. Rosenfield, R. Parthasarathy, J.D. Dunitz, Directional preferences of
nonbonded atomic contacts with divalent sulfur. 1. Electrophiles and
nucleophiles, J. Am. Chem. Soc. 99 (1977) 4860–4862.
[57] L. Ellgaard, L.W. Ruddock, The human protein disulphide isomerase
family: substrate interactions and functional properties, EMBO Rep. 6
(2005) 28–32.
[58] B. Wilkinson, H.F. Gilbert, Protein disulfide isomerase, Biochim.
Biophys. Acta Protein Proteomics 1699 (2004) 35–44.
[59] G. Tian, S. Xiang, R. Noiva, W.J. Lennarz, H. Schindelin, The crystal
structure of yeast protein disulfide isomerase suggests cooperativity
between its active sites, Cell 124 (2006) 61–73.
[60] C.W. Gruber, M. Cemazar, B. Heras, J.L. Martin, D.J. Craik, Protein
disulfide isomerase: the structure of oxidative folding, Trends Biochem.
Sci. 31 (2006) 455–464.
[61] S. Raje, C. Thorpe, Inter-domain redox communication in flavoenzymes
of the quiescin/sulfhydryl oxidase family: role of a thioredoxin domain in
disulfide bond formation, Biochemistry 42 (2003) 4560–4568.
[62] M. Huber-Wunderlich, R. Glockshuber, A single dipeptide sequence
modulates the redox properties of a whole enzyme family, Fold. Des. 3
(1998) 161–171.
[63] P.T. Chivers, K.E. Prehoda, R.T. Raines, The CXXC motif: a rheostat in
the active site, Biochemistry 36 (1997) 4061–4066.
[64] P.T. Chivers, M.C. Laboissiere, R.T. Raines, The CXXC motif:
imperatives for the formation of native disulfide bonds in the cell,
EMBO J. 15 (1996) 2659–2667.
[65] G. Krause, J. Lundstrom, J.L. Barea, C. Pueyo de la Cuesta,
A. Holmgren, Mimicking the active site of protein disulfide-isomerase
by substitution of proline 34 in Escherichia coli thioredoxin, J. Biol.
Chem. 266 (1991) 9494–9500.
[66] S. Quan, I. Schneider, J. Pan, A.V. Hacht, J.C. Bardwell, The CXXCmotif
is more than a redox rheostat, J. Biol. Chem. 282 (2007) 28823–28833.
[67] K.L. Hoober, S.S. Sheasley, H.F. Gilbert, C. Thorpe, Sulfhydryl oxidase
from egg white: a facile catalyst for disulfide bond formation in proteins
and peptides, J. Biol. Chem. 274 (1999) 22147–22150.
[68] S. Chakravarthi, C.E. Jessop, M. Willer, C.J. Stirling, N.J. Bulleid,
Intracellular catalysis of disulphide bond formation by the human
sulphydryl oxidase, QSOX1, Biochem. J. 404 (2007) 403–411.
[69] A. Tury, G. Mairet-Coello, F. Poncet, C. Jacquemard, P.Y. Risold,
D. Fellmann, B. Griffond, QSOX sulfhydryl oxidase in rat adenohy-
pophysis: localization and regulation by estrogens, J. Endocrinol. 183
(2004) 353–363.
[70] G. Mairet-Coello, A. Tury, A. Esnard-Feve, D. Fellmann, P.Y. Risold,
B. Griffond, FAD-linked sulfhydryl oxidase QSOX: topographic,
cellular, and subcellular immunolocalization in adult rat central nervous
system, J. Comp. Neurol. 473 (2004) 334–363.
[71] I. Wittke, R. Wiedemeyer, A. Pillmann, L. Savelyeva, F. Westermann,
M. Schwab, Neuroblastoma-derived sulfhydryl oxidase, a new member
of the sulfhydryl oxidase/Quiescin6 family, regulates sensitization to
interferon gamma-induced cell death in human neuroblastoma cells,
Cancer Res. 63 (2003) 7742–7752.
[72] S. Le Gall, A. Neuhof, T. Rapoport, The endoplasmic reticulum
membrane is permeable to small molecules, Mol. Biol. Cell 15 (2004)
447–455.
[73] S. Chakravarthi, C.E. Jessop, N.J. Bulleid, The role of glutathione in
disulphide bond formation and endoplasmic-reticulum-generated oxida-
tive stress, EMBO Rep. 7 (2006) 271–275.
[74] N.J. Darby, T.E. Creighton, Characterization of the active site cysteine
residues of the thioredoxin-like domains of protein disulfide isomerase,
Biochemistry 34 (1995) 16770–16780.
[75] H.F. Gilbert, Catalysis of thiol/disulfide exchange: single-turnover
reduction of protein disulfide-isomerase by glutathione and catalysis of
peptide disulfide reduction, Biochemistry 28 (1989) 7298–7305.
[76] H.F. Gilbert, Redox control of enzyme activities by thiol/disulfide
exchange, Methods Enzymol. 107 (1984) 330–351.
577E.J. Heckler et al. / Biochimica et Biophysica Acta 1783 (2008) 567–577[77] C.E. Jessop, S. Chakravarthi, R.H. Watkins, N.J. Bulleid, Oxidative
protein folding in the mammalian endoplasmic reticulum, Biochem.
Soc. Trans. 32 (2004) 655–658.
[78] A. Tury, G. Mairet-Coello, A. Esnard-Feve, B. Benayoun, P.Y. Risold,
B. Griffond, D. Fellmann, Cell-specific localization of the sulphydryl
oxidase QSOX in rat peripheral tissues, Cell Tissue Res. 323 (2006)
91–103.
[79] J.F. Musard, M. Sallot, P. Dulieu, A. Fraichard, C. Ordener, J.P. Remy-
Martin, M. Jouvenot, P. Adami, Identification and expression of a new
sulfhydryl oxidase SOx-3 during the cell cycle and the estrus cycle in
uterine cells, Biochem. Biophys. Res. Commun. 287 (2001) 83–91.
[80] G. Mairet-Coello, A. Tury, D. Fellmann, M. Jouvenot, B. Griffond,
Expression of SOx-2, a member of the FAD-dependent sulfhydryl
oxidase/quiescin Q6 gene family, in rat brain, Neuroreport 13 (2002)
2049–2051.
[81] J. Radom, D. Colin, F. Thiebault, M. Dognin-Bergeret, G. Mairet-Coello,
A. Esnard-Feve, D. Fellmann, M. Jouvenot, Identification and expression
of a new splicing variant of FAD-sulfhydryl oxidase in adult rat brain,
Biochim. Biophys. Acta 1759 (2006) 225–233.
[82] G. Mairet-Coello, A. Tury, D. Fellmann, P.Y. Risold, B. Griffond,
Ontogenesis of the sulfhydryl oxidase QSOX expression in rat brain,
J. Comp. Neurol. 484 (2005) 403–417.
[83] C. Amiot, J.F. Musard, M. Hadjiyiassemis, M. Jouvenot, D. Fellmann,
P.Y. Risold, P. Adami, Expression of the secreted FAD-dependent
sulfydryl oxidase (QSOX) in the guinea pig central nervous system, Mol.
Brain Res. 125 (2004) 13–21.
[84] M.V. Avshalumov, L. Bao, J.C. Patel, M.E. Rice, H2O2 signaling in the
nigrostriatal dopamine pathway via ATP-sensitive potassium channels:
issues and answers, Antioxid. Redox Signal. 9 (2007) 219–231.
[85] E.A. Veal, A.M. Day, B.A. Morgan, Hydrogen peroxide sensing and
signaling, Mol. Cell 26 (2007) 1–14.
[86] J.G. Moggs, T.C. Murphy, F.L. Lim, D.J. Moore, R. Stuckey,
K. Antrobus, I. Kimber, G. Orphanides, Anti-proliferative effect of estrogen
in breast cancer cells that re-express ERalpha is mediated by aberrant
regulation of cell cycle genes, J. Mol. Endocrinol. 34 (2005) 535–551.
[87] H.P. Mohammad, D.D. Seachrist, C.C. Quirk, J.H. Nilson, Reexpression
of p8 contributes to tumorigenic properties of pituitary cells and appears
in a subset of prolactinomas in transgenic mice that hypersecrete
luteinizing hormone, Mol. Endocrinol. 18 (2004) 2583–2593.
[88] K. Boon, E.C. Osorio, S.F. Greenhut, C.F. Schaefer, J. Shoemaker,
K. Polyak, P.J. Morin, K.H. Buetow, R.L. Strausberg, S.J. De Souza,
G.J. Riggins, An anatomy of normal and malignant gene expression,
Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11287–11292.
[89] X. Zhang, J. Rutledge, D.T. Armstrong, Studies on zona hardening in rat
oocytes that are matured in vitro in a serum-free medium, Mol. Reprod.
Dev. 28 (1991) 292–296.
[90] K. Iwamoto, K. Ikeda, N. Yonezawa, S. Noguchi, K. Kudo, S. Hamano,
M. Kuwayama, M. Nakano, Disulfide formation in bovine zona pellucida
glycoproteins during fertilization: evidence for the involvement of cystine
cross-linkages in hardening of the zona pellucida, J. Reprod. Fertil. 117
(1999) 395–402.
[91] D.L. Coppock, D. Cina-Poppe, S. Gilleran, The Quiescin Q6 gene
(QSCN6) is a fusion of two ancient gene families: thioredoxin and ERV1,
Genomics 54 (1998) 460–468.
[92] C.L. Farrell, F.H. Martin, R. Yabkowitz. Amgen Inc, USA 2001.
[93] K.B. Udupa, C. Bose, ASH Annual Meeting, vol. 106, American Society
of Hematology, 2005, p. 4270.
[94] S.M. Zanata, A.C. Luvizon, D.F. Batista, C.M. Ikegami, F.O. Pedrosa,
E.M. Souza, D.F. Chaves, L.F. Caron, J.V. Pelizzari, F.R. Laurindo,
L.S. Nakao, High levels of active quiescin Q6 sulfhydryl oxidase
(QSOX) are selectively present in fetal serum, Redox Rep. 10 (2005)
319–323.
[95] D.J. States, G.S. Omenn, T.W. Blackwell, D. Fermin, J. Eng, D.W.
Speicher, S.M. Hanash, Challenges in deriving high-confidence proteinidentifications from data gathered by a HUPO plasma proteome
collaborative study, Nat. Biotechnol. 24 (2006) 333–338.
[96] D.B. Martin, D.R. Gifford, M.E. Wright, A. Keller, E. Yi, D.R. Goodlett,
R. Aebersold, P.S. Nelson, Quantitative proteomic analysis of proteins
released by neoplastic prostate epithelium, Cancer Res. 64 (2004)
347–355.
[97] V. Kulasingam, E.P. Diamandis, Proteomic analysis of conditioned media
from three breastcancer cell lines: a mine for biomarkers and therapeutic
targets, Mol. Cell Proteomics (in press) [Electronic publication ahead of
print].
[98] D.W. Essex, M. Li, Redox modification of platelet glycoproteins, Curr.
Drug Targets 7 (2006) 1233–1241.
[99] P.A. Jordan, J.M. Gibbins, Extracellular disulfide exchange and the
regulation of cellular function, Antioxid. Redox Signal. 8 (2006)
312–324.
[100] Y.M. Go, D.P. Jones, Intracellular proatherogenic events and cell
adhesion modulated by extracellular thiol/disulfide redox state, Circula-
tion 111 (2005) 2973–2980.
[101] L.J. Matthias, P.J. Hogg, Redox control on the cell surface: implications
for HIV-1 entry, Antioxid. Redox Signal. 5 (2003) 133–138.
[102] C.R. Jonas, T.R. Ziegler, L.H. Gu, D.P. Jones, Extracellular thiol/disulfide
redox state affects proliferation rate in a human colon carcinoma (Caco2)
cell line, Free Radic. Biol. Med. 33 (2002) 1499–1506.
[103] A. Ramirez, B. Ramadan, J.D. Ritzenthaler, H.N. Rivera, D.P. Jones,
J. Roman, Extracellular cysteine/cystine redox potential controls lung
fibroblast proliferation and matrix expression through upregulation of
transforming growth factor-{beta}, Am. J. Physiol., Lung Cell. Mol.
Physiol. 293 (2007) L972–L981.
[104] B.K. Kaiser, D. Yim, I.T. Chow, S. Gonzalez, Z. Dai, H.H. Mann,
R.K. Strong, V. Groh, T. Spies, Disulphide-isomerase-enabled shedding
of tumour-associated NKG2D ligands, Nature 447 (2007) 482–486.
[105] D. Goplen, J. Wang, P.O. Enger, B.B. Tysnes, A.J. Terzis, O.D. Laerum,
R. Bjerkvig, Protein disulfide isomerase expression is related to the
invasive properties of malignant glioma, Cancer Res. 66 (2006)
9895–9902.
[106] K. Gumireddy, F. Sun, A.J. Klein-Szanto, J.M. Gibbins, P.A. Gimotty,
A.J. Saunders, P.G. Schultz, Q. Huang, In vivo selection for metastasis
promoting genes in the mouse, Proc. Natl. Acad. Sci. 104 (2007)
6696–6701.
[107] M.C. Ostrowski, M.K. Kistler, W.S. Kistler, Purification and cell-free
synthesis of a major protein from rat seminal vesicle secretion. A
potential marker for androgen action, J. Biol. Chem. 254 (1979)
383–390.
[108] J. Lee, G. Hofhaus, T. Lisowsky, Erv1p from Saccharomyces cerevisiae
is a FAD-linked sulfhydryl oxidase, FEBS Lett. 477 (1–2) (2000) 62–66.
[109] T. Lisowsky, J.E. Lee, L. Polimeno, A. Francavilla, G. Hofhaus,
Mammalian augmenter of liver regeneration protein is a sulfhydryl
oxidase, Dig. Liver Dis. 33 (2001) 173–180.
[110] J. Gerber, U. Muhlenhoff, G. Hofhaus, R. Lill, T. Lisowsky, Yeast
ERV2p is the first microsomal FAD-linked sulfhydryl oxidase of the
Erv1p/Alrp protein family, J. Biol. Chem. 276 (2001) 23486–23491.
[111] C.S. Sevier, J.W. Cuozzo, A. Vala, F. Aslund, C.A. Kaiser, A
flavoprotein oxidase defines a new endoplasmic reticulum pathway
for biosynthetic disulphide bond formation, Nat. Cell Biol. 3 (2001)
874–882.
[112] K. Bryson, L.J. McGuffin, R.L. Marsden, J.J. Ward, J.S. Sodhi,
D.T. Jones, Protein structure prediction servers at University College
London, Nucleic Acids Res. 33 (2005) W36–W38.
[113] K. Nakai, P. Horton, PSORT: a program for detecting sorting signals in
proteins and predicting their subcellular localization, Trends Biochem.
Sci. 24 (1999) 34–36.
[114] R. Linding, R.B. Russell, V. Neduva, T.J. Gibson, GlobPlot: exploring
protein sequences for globularity and disorder, Nucleic Acids Res. 31
(2003) 3701–3708.
